The Effect of PEMF for Patients With Knee OA
A Double-Blinded, Randomized-Control-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) for Patients With Knee Osteoarthritis
1 other identifier
interventional
80
1 country
1
Brief Summary
Health care costs are increasing alarmingly, which will impose an overwhelming economic burden to an aging society like that of Hong Kong. For example, degenerative musculoskeletal disorders such as osteoarthritis (OA) present a grand challenge with its high prevalence (\>40% in the elderly suffered from knee OA). OA is a debilitating progressive disease with typical symptoms such as acute pain causing loss of mobility Currently there is no cure for OA. Pharmacological treatment and new regenerative technologies such as stem cell therapy are actively being developed, but most of these options are very expensive per se, and side effects are not uncommon. Costeffectiveness is also a major consideration for devising new therapeutic modalities for OA. There are emerging evidences showing that pulsed electromagnetic field (PEMF) can modulae mitochondrial activities for muscle gain. PEMF exposure on top of regular exercise training may promote muscle regeneration and tissue healing. This study aims to conduct a double-blinded, randomized controlled trial to investigate the effect of PEMF treatment on knee pain in patients with knee OA. We hypothesize that PEMF treatment is effective to relief in pain and improve knee function in Knee OA subjects. Based on the aim of this study, older adult patients (aged 50 or above) with knee OA with Kellgren-Lawrence grade 2-4 by X-ray, have sedentary lifestyle (Tegner activity level less or equal to 3), no acute knee injuries in past 12 months, no muscle strain in past 12 months and not degenerative joint disease in other joints except the involved knee. To estimate the improvement of patients, isometric quadricep muscle strength, posture assessment, serum myokine level, serum vitamin D level and selfreported outcome with questionnaires will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started May 2022
Typical duration for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2022
CompletedFirst Submitted
Initial submission to the registry
August 12, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2024
CompletedDecember 20, 2023
December 1, 2023
2.4 years
August 12, 2022
December 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Peak torque of Isometric muscle strength
The peak torque in kgf will be recorded with in 2 trials in the 5 seconds isometric muscle strength test.
pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Secondary Outcomes (11)
International Physical Activity Questionnaire
pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Tegner activity score
pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Short Form-36 questionnaires (SF-36)
pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Serum myokine evaluation
pre PEMF treatment, 3-months, 6-months, and 12-months after the commencement of PEMF
The speed and rate of force development in 6 repetitions in chair stand test
pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
- +6 more secondary outcomes
Study Arms (2)
Treatment group
EXPERIMENTALSham group
SHAM COMPARATORInterventions
Subjects will receive PEMF treatment with the duration of 8 weeks, twice a week with total 16 treatment sessions and do the home-based exercise twice a week for 8 weeks.
Subjects will receive sham PEMF treatment with the duration of 8 weeks, twice a week with total 16 treatment sessions and do the home-based exercise twice a week for 8 weeks.
Eligibility Criteria
You may qualify if:
- Age 50 or above
- knee OA with Kellgren-Lawrence grade 2-4 by X-ray
- Sedentary lifestyle (Tegner activity level ≤ 3)
- No acute knee injuries in past 12 months
- No muscle strain in past 12 months
- No degenerative joint diseases in other joints except the involved knee
You may not qualify if:
- Age smaller than 50 years old
- Experienced any concomitant bone fracture, ACL injury, major meniscus injury
- Any rheumatological diseases
- Metal implants that would cause interference on MRI
- Previous contralateral knee injury
- Recent knee injections (prior 3 months)
- Physical inability to undertake testing procedures
- Pregnancy or possibility of pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Tim-Yun Ong
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- It is doubled blinded, a subject 's specific ID card will be provided for each of the enrolled subject and the investigators don't know whether it is PEMF or Sham treatment for that subject's specific ID card. And the investigator will ask the manufactory about the number of grouping at the end of the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
August 12, 2022
First Posted
September 21, 2022
Study Start
May 5, 2022
Primary Completion
September 15, 2024
Study Completion
September 15, 2024
Last Updated
December 20, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- starting 6 months after publication
- Access Criteria
- Journal reviewers
All IPD that underlie results in a publication.